Fingerprint
Dive into the research topics of 'Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nilofer S. Azad, Edwin M. Posadas, Virginia E. Kwitkowski, Seth M. Steinberg, Lokesh Jain, Christina M. Annunziata, Lori Minasian, Gisele Sarosy, Herbert L. Kotz, Ahalya Premkumar, Liang Cao, Deborah McNally, Catherine Chow, Helen X. Chen, John J. Wright, William D. Figg, Elise C. Kohn
Research output: Contribution to journal › Article › peer-review